An observational study in Myocardial Infarction, sponsored by Sahlgrenska University Hospital. Recruiting at 35 sites in Sweden. Open to participants aged 18 Years to 79 Years. Per ClinicalTrials.gov, last updated 2025-02-11.
Sponsored by Sahlgrenska University Hospital · Observational
Among 90 studies in Myocardial Infarction with a site in Sweden — 13 open to participants now, 22 under way, 4 of them phase 3. Myocardial Infarction · Sweden.
Among the 90 studies in Myocardial Infarction with a site in Sweden, this one is the 11th largest by planned enrollment of the 20 observational ones that give a count, is one of 3 that started in 2022, is one of 20 observational ones, reaches primary completion later than 7 of the 21 other live ones, and was the 73rd registered.
2,270 studies on the registry are indexed under Myocardial Infarction; 371 are open to participants now.
Browse Myocardial Infarction studies →13 of the 90 studies in Myocardial Infarction with a site in Sweden are open now. Recruiting first, the newest first:
Uppsala University · Sites in Sweden
Ages 18–55
Abcentra · Sites in Sweden, United States, Czechia and 6 more countries
Ages 18+
Karolinska Institutet · Sites in Sweden
Ages 18+ · Healthy volunteers
Karolinska Institutet · Sites in Sweden
Ages 18+
Uppsala University · Sites in Sweden
Ages 50–80
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 255 Myocardial Infarction studies recruiting now, 172 (67%) set no upper age limit and 26 (10%) stop at 75 or younger; 16 take children under 18; 27 take healthy volunteers.
This study: 18 Years to 79 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
90 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 11 · Phase 3 26 · Phase 4 11
First in 1997; this study’s year is marked. 3 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 4,000 is above the median of 568 across 814 observational studies indexed under Myocardial Infarction.
Median enrollment 875 across the 70 interventional studies, 5,518 across the 20 observational. Of the 64 that completed or were terminated, 21 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
38 of 90 have an industry lead sponsor. The 10 most frequent:
Sahlgrenska University Hospital is the lead sponsor of 263 studies on the registry; 68 are open to participants now.
Sahlgrenska University Hospital has 5 studies filed under Myocardial Infarction — fewer than ten, so there is no comparison to draw.
6 of the studies in Myocardial Infarction with a site in Sweden that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04957719Phase 3Viatris Innovation GmbHSelatogrel Outcome Study in Suspected Acute Myocardial Infarction | 2027-07 |
| NCT05889416Skane University HospitalThe Perfect-CR Implementation Study | 2026-12 |
| NCT03620266Ole Frobert, MD, PhDEffects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI | 2026-12-31 |
| NCT07706816Uppsala UniversityEvaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study | 2027-01-31 |
| NCT06927739AbcentraFocused Orticumab Research for Treating Inflammation in Coronary Arteries | 2027-02-08 |
Among the 90 studies in Myocardial Infarction with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The association between objectively measured physical activity intensities (light, moderate and vigorous), sedentary time and clinical outcomes has not been clarified in patients after a myocardial infarction.
The overall objective of the study is to explore associations between accelerometer measured physical activity and clinical outcomes after a myocardial infarction. Moreover, the association between changes in physical activity and outcomes will be assessed.
It is estimated to include 4000 patients with myocardial infarction during 2 years. Patients will wear the accelerometer for 7 days at follow-up visits (2 months and 1 year) after discharge. The investigators will examine the dose-response relations of several exposure variables from the accelerometer measurements with the outcomes.
Patients with myocardial infarction will be recruited at the first (2 months after discharge) cardiac rehabilitation follow-up visit at hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Diagnosis of a type 1 myocardial infarction registered in SWEDEHEART Age 18-79 years at discharge from hospital
Other: Accelerometer measurement
Study personnel will initiate an accelerometer and inform the patient to wear the accelerometer with an elastic belt on their right hip during waking hours for seven consecutive days. Moreover, patients are instructed to register their wear time in an activity diary in paper form. In addition, patients will register their working hours, if relevant. After seven days, patients send back the accelerometer and diary in a pre-paid envelope. The same procedure is repeated at the second follow-up visit at 1 year.
Major adverse cardiovascular event (MACE)
The composite incidence of cardiovascular mortality, non-fatal myocardial infarction, non-fatal ischemic stroke, coronary revascularization, hospitalization for new or worsening heart failure
Time frame: 1 year after the index cardiac event
Cardiovascular mortality
Incidence of cardiovascular mortality
Time frame: 1 year after the index cardiac event
Non-fatal myocardial infarction
Incidence of non-fatal myocardial infarction
Time frame: 1 year after the index cardiac event
Non-fatal ischemic stroke
Incidence of non-fatal ischemic stroke
Time frame: 1 year after the index cardiac event
Coronary revascularization
Incidence of coronary revascularization
Time frame: 1 year after the index cardiac event
Heart failure
Incidence of hospitalization for new or worsening heart failure
Time frame: 1 year after the index cardiac event
Major adverse cardiovascular event (MACE)
The composite incidence of cardiovascular mortality, non-fatal myocardial infarction, non-fatal ischemic stroke, coronary revascularization, hospitalization for new or worsening heart failure
Time frame: 3 years after the index cardiac event
Cardiovascular mortality
Incidence of cardiovascular mortality
Time frame: 3 years after the index cardiac event
Non-fatal myocardial infarction
Incidence of non-fatal myocardial infarction
Time frame: 3 years after the index cardiac event
Non-fatal ischemic stroke
Incidence of non-fatal ischemic stroke
Time frame: 3 years after the index cardiac event
Coronary revascularization
Incidence of coronary revascularization
Time frame: 3 years after the index cardiac event
Heart failure
Incidence of hospitalization for new or worsening heart failure
Time frame: 3 years after the index cardiac event
All-cause death
Incidence of all-cause death
Time frame: 1 year after the index cardiac event
All-cause death
Incidence of all-cause death
Time frame: 3 year after the index cardiac event
Smoking status
0=Never smoker, 1=Former smoker \> 1 month, 2=Smoker
Time frame: 1 year after the index cardiac event
The Swedish Healthy diet questionnaire
Four questions with Likert scale 0-3 points. Higher scores indicate better outcomes
Time frame: 1 year after the index cardiac event
Health-related quality of life (EuroQol- 5 Dimension)
EuroQol- 5 Dimension (EQ-5D-3L) The EQ-5D-3L comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. Higher scores indicate better outcomes.
Time frame: 1 year after the index cardiac event
Health-related quality of life (EQ visual analogue scale)
EQ visual analogue scale (EQ VAS). The EQ VAS records the respondent's self-rated health on a vertical, visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'.
Time frame: 1 year after the index cardiac event
Triglycerides
Plasma levels of triglycerides (mmol/L). Higher values indicate worse outcome.
Time frame: 1 year after the index cardiac event
High-density lipoprotein (HDL) cholesterol
Plasma levels of HDL (mmol/L). Higher values indicate better outcome
Time frame: 1 year after the index cardiac event
Low-density lipoprotein (LDL) cholesterol
Plasma levels of LDL cholesterol (mmol/L). Higher values indicate worse outcome
Time frame: 1 year after the index cardiac event
Hemoglobin A1c (HbA1c)
HbA1c (mmol/L). Measures the amount of blood sugar. Higher values indicate worse outcome
Time frame: 1 year after the index cardiac event
Blood pressure
mmHg
Time frame: 1 year after the index cardiac event
Body weight
kg
Time frame: 1 year after the index cardiac event
Waist circumference
cm
Time frame: 1 year after the index cardiac event
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Started Apr 2022 (actual). Primary completion is estimated for Apr 2026, 48 months after the start.
Of 296 non-industry observational studies under Myocardial Infarction, half reached primary completion within 54 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 140. This study's planned 48 months is below that.
Counting every sponsor, half of 333 studies reached it within 48 months; a quarter within 17 and three quarters within 114.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sahlgrenska University Hospital →